Skip Navigation

Cardiovascular Research 2004 63(3):510-519; doi:10.1016/j.cardiores.2004.03.027
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Du, X.-J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Du, X.-J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Gender modulates cardiac phenotype development in genetically modified mice

Xiao-Jun Du*

Experimental Cardiology Laboratory, Wynn Domain, Baker Heart Research Institute PO Box 6492, Commercial Road, Melbourne, Victoria 3004, Australia

* Tel.: +61-3-92762028; fax: +61-3-85321100. Email address: xiaojun.du{at}baker.edu.au

Recent research using genetically modified mice has revealed significant sex differences in cardiac phenotypes. In the majority of strains, females display a lower mortality, less severe hypertrophy, better preserved function and mitigated cardiac pathology compared with male counterparts. Thus, gender is an independent determinant for the development of cardiac phenotype in murine models. While there is strong evidence for estrogen as a cardiac protector, emerging evidence indicates adverse actions of testicular hormones that might be responsible in part for the sex differences. Studies using mouse models have also revealed novel information on signalling mechanisms mediating the sex difference.

KEYWORDS Hypertrophy; Heart failure; Gender; Estrogens; Transgenic animal models

Time for primary review 28 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
S. W.M. van den Borne, V. A.M. van de Schans, A. E. Strzelecka, H. T.M. Vervoort-Peters, P. M. Lijnen, J. P.M. Cleutjens, J. F.M. Smits, M. J.A.P. Daemen, B. J.A. Janssen, and W. M. Blankesteijn
Mouse strain determines the outcome of wound healing after myocardial infarction
Cardiovasc Res, November 1, 2009; 84(2): 273 - 282.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Swinnen, D. Vanhoutte, G. C. Van Almen, N. Hamdani, M. W.M. Schellings, J. D'hooge, J. Van der Velden, M. S. Weaver, E. H. Sage, P. Bornstein, et al.
Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy
Circulation, October 20, 2009; 120(16): 1585 - 1597.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
G. E. Haddad, L. J. Saunders, S. D. Crosby, M. Carles, F. del Monte, K. King, M. R. Bristow, F. G. Spinale, T. E. Macgillivray, M. J. Semigran, et al.
Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences
Physiol Genomics, April 1, 2008; 33(2): 267 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
B. Colom, J. Oliver, P. Roca, and F. J. Garcia-Palmer
Caloric restriction and gender modulate cardiac muscle mitochondrial H2O2 production and oxidative damage
Cardiovasc Res, June 1, 2007; 74(3): 456 - 465.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Umans, L. Cox, M. Tjwa, V. Bito, L. Vermeire, K. Laperre, K. Sipido, L. Moons, D. Huylebroeck, and A. Zwijsen
Inactivation of Smad5 in Endothelial Cells and Smooth Muscle Cells Demonstrates that Smad5 Is Required for Cardiac Homeostasis
Am. J. Pathol., May 1, 2007; 170(5): 1460 - 1472.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. F. Deschepper and B. Llamas
Hypertensive Cardiac Remodeling in Males and Females: From the Bench to the Bedside
Hypertension, March 1, 2007; 49(3): 401 - 407.
[Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
L. J Ellmers, N. J A Scott, J. Piuhola, N. Maeda, O. Smithies, C. M Frampton, A M. Richards, and V. A Cameron
Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis
J. Mol. Endocrinol., February 1, 2007; 38(2): 245 - 257.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. D. Lekgabe, S. G. Royce, T. D. Hewitson, M. L. K. Tang, C. Zhao, X. L. Moore, G. W. Tregear, R. A. D. Bathgate, X.-J. Du, and C. S. Samuel
The Effects of Relaxin and Estrogen Deficiency on Collagen Deposition and Hypertrophy of Nonreproductive Organs
Endocrinology, December 1, 2006; 147(12): 5575 - 5583.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. Mahmoodzadeh, S. Eder, J. Nordmeyer, E. Ehler, O. Huber, P. Martus, J. Weiske, R. Pregla, R. Hetzer, and V. Regitz-Zagrosek
Estrogen receptor alpha up-regulation and redistribution in human heart failure
FASEB J, May 1, 2006; 20(7): 926 - 934.
[Abstract] [Full Text] [PDF]

Home page
 Clin Med ResHome page
C. S. Samuel
Relaxin: Antifibrotic Properties and Effects in Models of Disease
Clin. Med. Res., November 1, 2005; 3(4): 241 - 249.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. N. Ladd, G. Taffet, C. Hartley, D. L. Kearney, and T. A. Cooper
Cardiac Tissue-Specific Repression of CELF Activity Disrupts Alternative Splicing and Causes Cardiomyopathy
Mol. Cell. Biol., July 15, 2005; 25(14): 6267 - 6278.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.